For the quarter ending 2025-09-30, PIII made $345,253K in revenue. -$31,587K in net income. Net profit margin of -9.15%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Total operating revenue | 345,253 | 355,788 | 373,225 | 379,587 |
| Medical expense | 369,789 | 351,350 | 372,043 | 396,141 |
| Premium deficiency reserve | -23,736 | -5,967 | -6,962 | 19,464 |
| Corporate, general and administrative expense | 22,139 | 23,295 | 24,999 | 29,384 |
| Impairment of assets held for sale | - | - | - | 2,015 |
| Sales and marketing expense | 251 | 151 | 181 | 392 |
| Depreciation and amortization | 21,033 | 21,083 | 21,052 | 21,346 |
| Total operating expense | 389,476 | 389,912 | 411,313 | 470,754 |
| Operating loss | -44,223 | -34,124 | -38,088 | -91,167 |
| Interest expense, net | -20,527 | -10,145 | -8,725 | -5,545 |
| Gain (loss) on disposition of assets | - | - | - | 6,635 |
| Mark-to-market of stock warrants | 2,540 | -2,002 | -3,322 | -3,852 |
| Other | -2,160 | 583 | 318 | 361 |
| Total other income (expense) | -25,227 | -7,560 | -5,085 | 5,302 |
| Loss before income taxes | -69,450 | -41,684 | -43,173 | -85,865 |
| Income tax benefit (provision) | 11 | 1,981 | 1,073 | 3,512 |
| Net loss | -69,461 | -43,665 | -44,246 | -89,377 |
| Less net loss attributable to redeemable non-controlling interest | -37,874 | -23,303 | -23,766 | -50,718 |
| Net loss attributable to controlling interest | -31,587 | -20,362 | -20,480 | -38,658 |
| Basic (in dollars per share) | -9.67 | -6.23 | -6.28 | -0.28 |
| Basic (in shares) | 3,268,000 | 3,267,000 | 3,260,000 | -76,658,000 |
| Diluted (in dollars per share) | -9.67 | -6.23 | -6.28 | -0.31 |
| Diluted (in shares) | 3,268,000 | 3,267,000 | 3,260,000 | -79,393,000 |
P3 Health Partners Inc. (PIII)
P3 Health Partners Inc. (PIII)